CLINICAL_TRIALS
research
· 2026-04-07
Clinical Trial Update: A Phase 2 Study of HW211026 in Participants With Actinic Keratosis [Phase 2]
Summary
A Phase 2 clinical trial of HW211026 for actinic keratosis is registered, with recruitment not yet started.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Conditions: Actinic Keratosis | Phase 2 | Status: NOT_YET_RECRUITING